no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Abemaciclib for treating patients with HR+, HER2- advanced/metastatic breast cancer in Spain: a real-world study
|
Blancas, I. |
|
|
175 |
S1 |
p. S59-S60 |
article |
2 |
Accelerated partial breast irradiation (APBI) in a single 18 Gy fraction with high-dose-rate brachytherapy (HDR)
|
Anchuelo, J. |
|
|
175 |
S1 |
p. S49-S50 |
article |
3 |
Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy after second conservative-surgery
|
Martinez Montesinos, I. |
|
|
175 |
S1 |
p. S47-S48 |
article |
4 |
Accuracy of pre-operative axillary US and biopsy in breast cancer patients
|
Hudson-Phillips, S. |
|
|
175 |
S1 |
p. S29 |
article |
5 |
A comparative analysis between vertical rectus abdominis myocutaneous (VRAM) flap and transverse rectus abdominis myocutaneous (TRAM) flap as options for post-mastectomy chest wall reconstruction
|
Bhattacharya, A. |
|
|
175 |
S1 |
p. S21 |
article |
6 |
A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study
|
Miglietta, F. |
|
|
175 |
S1 |
p. S3 |
article |
7 |
Advanced breast cancer journey: a consensus guidance from a multidisciplinary panel for improving clinical practice in Portugal
|
Pinto, L. |
|
|
175 |
S1 |
p. S70 |
article |
8 |
Advanced breast cancer treatment after CDK4/6– inhibitors - the experience of a Hospital Center
|
Costa, M. |
|
|
175 |
S1 |
p. S70-S71 |
article |
9 |
Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: a survey within the MINDACT cohort
|
Lopes Cardozo, J. |
|
|
175 |
S1 |
p. S64 |
article |
10 |
A higher number of HSP70 positive immune cells in a deep layer of TNBC is associated with a higher FOXP3 expression and a higher risk of axillary lymph node involvement
|
Car Peterko, A. |
|
|
175 |
S1 |
p. S80 |
article |
11 |
AI-based smartphone App using a single-lead ECG for automated QTc diagnostics in oncology
|
Tonk, C.H. |
|
|
175 |
S1 |
p. S71 |
article |
12 |
Alternative breast cancer localisation techniques in Wales: an early experience
|
Warren, A. |
|
|
175 |
S1 |
p. S16 |
article |
13 |
A machine learning (ML) approach for identifying genetic biomarkers and new targets associated with impaired survival of breast cancer patients
|
Sanz Martin, G. |
|
|
175 |
S1 |
p. S82 |
article |
14 |
A multicenter cohort of breast cancer patients with long-term 125I targeted axillary dissection
|
Munck, F. |
|
|
175 |
S1 |
p. S14-S15 |
article |
15 |
A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients
|
Karanasiou, G. |
|
|
175 |
S1 |
p. S40 |
article |
16 |
Analysis of factors with impact on duration of hospitalisation for patients operated for breast cancer during COVID 19 pandemic
|
Maksimovic, Z. |
|
|
175 |
S1 |
p. S15-S16 |
article |
17 |
Analysis of fatty acid composition profile of tumoral and non-tumoral tissues from breast cancer patients
|
Gonzalez Yebra, B. |
|
|
175 |
S1 |
p. S84-S85 |
article |
18 |
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancer cases excludes additional high-impact susceptibility genes
|
Loveday, C. |
|
|
175 |
S1 |
p. S39 |
article |
19 |
An expanded 29-gene HER2 signature robustly identifies genomic HER2-Type early-stage breast tumors
|
Ellappalayam, A. |
|
|
175 |
S1 |
p. S78-S79 |
article |
20 |
An individualized breast cancer risk assessment model for women attending screening in BreastScreen Norway
|
Louro, J. |
|
|
175 |
S1 |
p. S8-S9 |
article |
21 |
A novel biomarker to predict DNA-Repair-inhibitor response in stage I-III high risk breast cancer patients
|
Barcaru, A. |
|
|
175 |
S1 |
p. S79 |
article |
22 |
Anthracycline versus no anthracycline neoadjuvant therapy for HER2 breast cancer: real world evidence
|
Soares De Pinho, I. |
|
|
175 |
S1 |
p. S62 |
article |
23 |
Anxiety and depression screening during neoadjuvant chemotherapy treatment in early breast cancer patients: a multicenter longitudinal observational study
|
Rodrigues, J. |
|
|
175 |
S1 |
p. S36 |
article |
24 |
A Phase III, Randomized, Multicenter, Double-blind Study to Compare Efficacy and Safety of EG12014 (EirGenix Trastuzumab) with Herceptin® as Neoadjuvant Treatment in Combination with Anthracycline/Paclitaxel-based Systemic Therapy in Patients with HER2-positive Early Breast Cancer
|
Henneberg, J. |
|
|
175 |
S1 |
p. S60 |
article |
25 |
A retrospective evaluation of factors associated with upstage to malignancy for breast lesions of uncertain malignant potential (B3): findings from an American cohort
|
Casaubon, J. |
|
|
175 |
S1 |
p. S95-S96 |
article |
26 |
Assessing the application of multidisciplinary management of locally advanced breast cancer in Egyptian female patients at Alexandria surgical oncology unit
|
AbouElnagah, G. |
|
|
175 |
S1 |
p. S70 |
article |
27 |
Assessment and management of lesions of uncertain malignant potential of the breast at Trieste Breast Unit: a single center experience
|
Scomersi, S. |
|
|
175 |
S1 |
p. S89 |
article |
28 |
Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors
|
Kim, K.H. |
|
|
175 |
S1 |
p. S41 |
article |
29 |
A study of the anti-proliferative and anti-migration effects of polyphenol compounds in Maltese extra virgin olive oil on different breast cancer cell lines
|
Tovar Parra, J.D. |
|
|
175 |
S1 |
p. S76 |
article |
30 |
A systematic review on management of breast cancer patients during the covid 19 pandemic: To assess if there was a clinical delay in treatment and patient perception on delayed treatment. Literature review of the current covid 19 management guidelines for breast cancer patients
|
Shah, R.N. |
|
|
175 |
S1 |
p. S65 |
article |
31 |
Author Index
|
|
|
|
175 |
S1 |
p. S97-S108 |
article |
32 |
Axillary Nodal Management in the setting of Neoadjuvant Chemotherapy
|
Pérez Cartón, S. |
|
|
175 |
S1 |
p. S66 |
article |
33 |
Bacterial β-glucuronidase activity in postmenopausal breast cancer patients: a pilot study
|
Hillege, L. |
|
|
175 |
S1 |
p. S84 |
article |
34 |
Behavior of locally advanced invasive lobular carcinoma according to primary treatment
|
Sanchez Mateos Enrique, M.R. |
|
|
175 |
S1 |
p. S67 |
article |
35 |
Black seed oil supplement had positive effects on blood concentration and mRNA expression levels of estrogen and SHBG in premenopausal women with overweight and obesity: a crossover, double blind, placebo controlled randomized clinical trial
|
Razmpoosh, E. |
|
|
175 |
S1 |
p. S42 |
article |
36 |
Borderline and malignant phyllodes tumors of the breast: a population-based study of all cases in the Netherlands 1989–2020
|
Bartels, S. |
|
|
175 |
S1 |
p. S4 |
article |
37 |
Borderline phyllodes tumors do not require wide resection margin
|
Yoon, K. |
|
|
175 |
S1 |
p. S21-S22 |
article |
38 |
Breast cancer after In Vitro Fecundation: Ovary response and prognostic factors
|
Izquierdo, M. |
|
|
175 |
S1 |
p. S61 |
article |
39 |
Breast cancer and pregnancy: about a series of cases and review of the literature
|
Bannour, B. |
|
|
175 |
S1 |
p. S75 |
article |
40 |
Breast cancer axillary dissection a “lost procedure, sometimes still necessary…” how to prevent the lost of a surgical technique using cadaver body and Simlife
|
Bau’, M.G. |
|
|
175 |
S1 |
p. S12-S13 |
article |
41 |
Breast cancer in elderly patients in a Venezuelan breast center. How we manage the axilla
|
Acosta-Marin, V. |
|
|
175 |
S1 |
p. S19-S20 |
article |
42 |
Breast cancer management with CDK4/6 inhibitors as first line treatment: a single institution retrospective review
|
Villa, F. |
|
|
175 |
S1 |
p. S69-S70 |
article |
43 |
Breast cancer nutritional risk factors: insights from the Tesco 1.0 dataset
|
Yilmaz, D. |
|
|
175 |
S1 |
p. S42-S43 |
article |
44 |
Breast Cancer Whole Blood Screening: Analytical and Clinical Performance from Early Analysis of the International Identify Breast Cancer (IDBC) Study
|
Bundred, N. |
|
|
175 |
S1 |
p. S8 |
article |
45 |
Budget impact model for magnetic tracers in the detection of sentinel lymph nodes for operable breast cancer
|
Belaroussi, I. |
|
|
175 |
S1 |
p. S23 |
article |
46 |
Capsaicin patch 179 mg (CP) for the management of localized neuropathic pain (LNP) after breast cancer (BC) treatment
|
Anchuelo, J. |
|
|
175 |
S1 |
p. S57 |
article |
47 |
Causes and consequences of delayed diagnosis in breast cancer screening; focus on mammographic features and tumour characteristics
|
Van Der Veer, E. |
|
|
175 |
S1 |
p. S30 |
article |
48 |
Caveolin-1 haplotypes as predictor for locoregional recurrence in breast cancer
|
Godina, C. |
|
|
175 |
S1 |
p. S85 |
article |
49 |
Cell-free DNA concentration in patients with different molecular subtypes of breast cancer
|
Karathanasis, P. |
|
|
175 |
S1 |
p. S83 |
article |
50 |
Change in Shoulder range of motion, strength and the disabilities of the arm, shoulder, and hand (DASH) within 6 months after breast cancer surgery: A Prospective Observational Study
|
Ryu, J. |
|
|
175 |
S1 |
p. S10-S11 |
article |
51 |
Characteristics of patients with metastatic luminal breast cancer (MLBC) and ESR1 polymorphism
|
Tarasenko, T. |
|
|
175 |
S1 |
p. S71 |
article |
52 |
Circulating microRNAs for early detection of therapy-related cardiac events in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO
|
Pizzamiglio, S. |
|
|
175 |
S1 |
p. S77-S78 |
article |
53 |
Clinical and Experimental investigation of AKT1/2/3 isoforms indicated non-redundant isoform specific role in driving stemness and Cisplatin resistance in TNBCs
|
Malik, F. |
|
|
175 |
S1 |
p. S86 |
article |
54 |
Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
|
Doege, D. |
|
|
175 |
S1 |
p. S55 |
article |
55 |
Clinical benefit and tolerability of CDK4/6 inhibitors in the treatment of breast cancer advanced in the geriatric population – real life data from a Hospital Center
|
Costa, M. |
|
|
175 |
S1 |
p. S63 |
article |
56 |
Clinicopathologic Risk Factors of Brain Metastasis in Breast Cancer Patients: A Systematic Review and Meta-analysis
|
Garcia, K.B. |
|
|
175 |
S1 |
p. S94 |
article |
57 |
Co-expressing genes with TACSTD2 and interacting microRNAs in patients with recurrent luminal breast cancers
|
Kok, V.C. |
|
|
175 |
S1 |
p. S76 |
article |
58 |
Comparison of ER, PR, HER2 and Ki67 expression by MammaTyper® RT-qPCR and immunohistochemistry (IHC) on needle core biopsies of breast cancer
|
Shaaban, A. |
|
|
175 |
S1 |
p. S87-S88 |
article |
59 |
Comparison of Technetium (Tc)- and SPIO-guided Sentinel Lymph Node Biopsy (SLNB) in Patients with Neoadjuvant Chemotherapy in Early Breast Cancer – first retrospective data
|
Munawwar, B. |
|
|
175 |
S1 |
p. S14 |
article |
60 |
Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
|
Ploumen, R. |
|
|
175 |
S1 |
p. S1 |
article |
61 |
Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients
|
Kumar, R. |
|
|
175 |
S1 |
p. S33 |
article |
62 |
Concordance between manual pathologist scoring and an Artificial Intelligence Deep Learning-based algorithm for Ki-67 immunohistochemical scoring in breast cancer
|
Badr, N.M. |
|
|
175 |
S1 |
p. S59 |
article |
63 |
Contents
|
|
|
|
175 |
S1 |
p. iv-v |
article |
64 |
Contrast Enhanced Mammography in Breast Cancer Surveillance
|
Elder, K. |
|
|
175 |
S1 |
p. S8 |
article |
65 |
Contrast enhanced mammography in further assessment of screen-detected breast cancer
|
Maccallum, C. |
|
|
175 |
S1 |
p. S33-S34 |
article |
66 |
Contribution and performance of subsidized mammography and breast cancer detection rate in underserved populations of rural and urban areas of Sindh, Pakistan
|
Shamsi, U. |
|
|
175 |
S1 |
p. S44-S45 |
article |
67 |
Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs
|
Jongbloed, L. |
|
|
175 |
S1 |
p. S60-S61 |
article |
68 |
Cost-effectiveness of first-line ribociclib use vs palbociclib in the treatment of postmenopausal women with HR+/HER2− advanced breast cancer: analysis based on final OS results of MONALEESA-2 and PALOMA-2
|
Cameron, D.A. |
|
|
175 |
S1 |
p. S67 |
article |
69 |
Coverage and Socio-economic inequalities in breast cancer screening in Low- and Middle-Income Countries: Analysis of Demographic and Health Surveys between 2010 and 2019
|
Abila, D.B. |
|
|
175 |
S1 |
p. S45 |
article |
70 |
COVID-19, breast cancer care, and social determinants of health: a cross-sectional study to investigate the impact of a pandemic on health and health care
|
Myers, C. |
|
|
175 |
S1 |
p. S75 |
article |
71 |
Cumulative risks of false positive recall and screen detected breast cancer after multiple rounds of screening
|
Kregting, L. |
|
|
175 |
S1 |
p. S44 |
article |
72 |
Cytokine identification in seroma fluid after mastectomy in breast cancer patients – first results of SerMa pilot study subgroup
|
Ditsch, N. |
|
|
175 |
S1 |
p. S86 |
article |
73 |
Depression, anxiety and stress among women with breast cancer in Sri Lanka
|
Seneviratne, S. |
|
|
175 |
S1 |
p. S55 |
article |
74 |
Depression, anxiety and the risk of breast cancer among premenopausal and postmenopausal women: an individual participant data meta-analysis
|
Basten, M. |
|
|
175 |
S1 |
p. S95 |
article |
75 |
Depression, loneliness and apathy in older breast cancer survivors: five-year follow-up from the Climb Every Mountain study
|
Lemij, A. |
|
|
175 |
S1 |
p. S53 |
article |
76 |
Designing digital health tools for helping metastatic breast cancer patients manage symptoms at home and optimize quality of life: PRICE and MET-GUIDE
|
Kassianos, A. |
|
|
175 |
S1 |
p. S35 |
article |
77 |
Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience
|
Caldart, A. |
|
|
175 |
S1 |
p. S38-S39 |
article |
78 |
Developing an effective self-management web-based intervention using co-designed patient and multidisciplinary research: ePainQ
|
Hartup, S. |
|
|
175 |
S1 |
p. S56 |
article |
79 |
Development and Validation of a Digital-Artificial Intelligent (AI) enabled Assay to predict early-stage breast cancer recurrence
|
Fernandez, G. |
|
|
175 |
S1 |
p. S85 |
article |
80 |
Development of a multiplex dPCR assay for ERBB2 amplification in breast cancer
|
Meng, P. |
|
|
175 |
S1 |
p. S80 |
article |
81 |
Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer
|
Gough, M. |
|
|
175 |
S1 |
p. S81-S82 |
article |
82 |
Digital health applications to support patients with breast cancer: Effects of two tailored, dialogue-based programs on quality of life
|
Holtdirk, F. |
|
|
175 |
S1 |
p. S56-S57 |
article |
83 |
Does fertility preservation affect the onset of the oncological treatment and the response to neoadjuvant chemotherapy in breast cancer?
|
Baulies, S. |
|
|
175 |
S1 |
p. S40-S41 |
article |
84 |
Does preservation of intercostobrachial nerve during axillary lymph node dissection in breast cancer have a positive impact on chronic pain, sensory changes, and quality of life?
|
Vishnoi, J.R. |
|
|
175 |
S1 |
p. S29 |
article |
85 |
Does the use of an Intraoperative device to assess margins reduce need for reexcison after breast conserving surgery: Multicentre Randomised Controlled Trial
|
Bundred, N. |
|
|
175 |
S1 |
p. S5 |
article |
86 |
Early detection of breast cancer in high-risk women based on longitudinal changes in serum-based proteins: the TESTBREAST study
|
Hagenaars, S. |
|
|
175 |
S1 |
p. S1 |
article |
87 |
Early integrated rehabilitation helps maintain good cognitive function in breast cancer patients – a comparison of self-reported cognitive function between the intervention group and control group in a prospective study in 511 patients
|
Mavric, Z. |
|
|
175 |
S1 |
p. S41-S42 |
article |
88 |
Editorial Board
|
|
|
|
175 |
S1 |
p. ii |
article |
89 |
Effectiveness of a nurse-navigation intervention in vulnerable breast cancer patients – The Rebecca Study
|
Bidstrup, P.E. |
|
|
175 |
S1 |
p. S7 |
article |
90 |
Effect of a 24 week home-based walking program on the incidence of aromatase inhibitor induced musculoskeletal pain: The WISE prospective, randomized, multicenter trial [SAKK 95/17]
|
Honecker, F. |
|
|
175 |
S1 |
p. S43-S44 |
article |
91 |
Effect of Covid-19 pandemic on breast cancer disease progression
|
Butt, A. |
|
|
175 |
S1 |
p. S42 |
article |
92 |
Effect of nodal status before and after neoadjuvant chemotherapy on prognosis in breast cancer: a Dutch population-based study
|
De Wild, S. |
|
|
175 |
S1 |
p. S12 |
article |
93 |
Effect of socio-economic status and acculturation on breast cancer screening in Asian American women
|
Stan, D. |
|
|
175 |
S1 |
p. S29-S30 |
article |
94 |
Efficacy and safety of the biosimilar QL1206 compared with denosumab in breast cancer with bone metastases: subgroup analyses of a phase III study
|
Li, H. |
|
|
175 |
S1 |
p. S68 |
article |
95 |
Efficacy of pre-operative axillary ultrasonography in excluding nodal disease – can it replace sentinel lymph node biopsy in early stage breast cancer?
|
Javed, N. |
|
|
175 |
S1 |
p. S27 |
article |
96 |
Epigenetic silencing of P16INK4a hasten disease stage in Carcinoma of Breast: A hospital-based study of North India
|
Singh, S. |
|
|
175 |
S1 |
p. S37 |
article |
97 |
ERBB2 mRNA expression in HER2-low breast cancer
|
Teng, X. |
|
|
175 |
S1 |
p. S93 |
article |
98 |
Evaluation and optimization of treatment for patients with metastatic breast cancer and receiving CDK4/6-inhibitors
|
Henze, F. |
|
|
175 |
S1 |
p. S34-S35 |
article |
99 |
Evaluation of effect of post-biopsy mammogram on marker clip migration after Stereotactic-Guided Core Needle Breast Biopsy
|
Baker, L. |
|
|
175 |
S1 |
p. S30-S31 |
article |
100 |
Evaluation of fertility preservation in young breast cancer patients
|
Beketic Oreskovic, L. |
|
|
175 |
S1 |
p. S53-S54 |
article |
101 |
Evaluation of neoadjuvant chemotherapy response in breast cancer: radiological and pathological concordance
|
Martínez Pairés, M. |
|
|
175 |
S1 |
p. S65-S66 |
article |
102 |
Evaluation of patient reported outcome measure following periareolar (Benelli) mammoplasty using BREAST-Q: Single centre 5-year experience
|
Rapisarda, F. |
|
|
175 |
S1 |
p. S20 |
article |
103 |
Exosomes from mistletoe treated tumor cells for the stimulation of immune cells
|
Sahay, J. |
|
|
175 |
S1 |
p. S36 |
article |
104 |
Exploring the impact of metastatic breast cancer support group in Nigeria
|
Nwosu-Zitta, T. |
|
|
175 |
S1 |
p. S74 |
article |
105 |
Exploring the lymph node’s microenvironment for personalized management of luminal A breast cancer
|
Gante, I. |
|
|
175 |
S1 |
p. S81 |
article |
106 |
Exploring timely perspectives of embodiment in women diagnosed with breast cancer undergoing oncoplastic breast surgery: A qualitative study from a plastic- and breast surgical outpatient clinic
|
Thestrup Hansen, S. |
|
|
175 |
S1 |
p. S53 |
article |
107 |
External validation and clinical utility assessment of PREDICT v2.2 prognostic model in young, node-negative, systemic treatment-naïve breast cancer patients
|
Wang, Y. |
|
|
175 |
S1 |
p. S7-S8 |
article |
108 |
Factors affecting Quality of Life among breast cancer survivors
|
Fatima, A. |
|
|
175 |
S1 |
p. S11 |
article |
109 |
False-Negative Rates Between Pathological Lymph Node Status Between Ductal and Lobular Breast Cancer: A Retrospective Cohort Study of 83,152 Patients
|
Oemrawsingh, A. |
|
|
175 |
S1 |
p. S92 |
article |
110 |
Ferromagnetic seed in breast surgery (lumpectomy and targeted axillary dissection (TAD)): our experience since 2018
|
Martínez Mateo, Y.A. |
|
|
175 |
S1 |
p. S26 |
article |
111 |
Finding patient-reported deterrents to adjunct Breast Cancer screening among patients with dense breast tissues. A cross sectional study in Pakistan
|
Fatima, A. |
|
|
175 |
S1 |
p. S43 |
article |
112 |
First results on acute skin toxicity in model-based selected breast cancer patients treated with adjuvant intensity modulated proton therapy
|
Sattler, M.G.A. |
|
|
175 |
S1 |
p. S48 |
article |
113 |
Fluorescence guided fully endoscopic axillary dissection for locally advanced breast cancer. A feasible novel technique
|
York, E. |
|
|
175 |
S1 |
p. S28 |
article |
114 |
Forty-eight weeks of yogic intervention improves serum interleukins IL-10 and IL-1β along with fatigue and quality of life during the radiotherapy/chemotherapy in breast cancer patients: a randomized control study
|
Mishra, A. |
|
|
175 |
S1 |
p. S6 |
article |
115 |
GC-MS based untargeted approach reveals metabolic perturbation in Tamoxifen resistant breast cancer cells
|
Mishra, A. |
|
|
175 |
S1 |
p. S75-S76 |
article |
116 |
Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO
|
Di Cosimo, S. |
|
|
175 |
S1 |
p. S78 |
article |
117 |
Genome wide association study of long-term patient-reported outcomes following radiotherapy for breast cancer – results from the REQUITE cohort study
|
Jandu, H. |
|
|
175 |
S1 |
p. S38 |
article |
118 |
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
|
Curtit, E. |
|
|
175 |
S1 |
p. S59 |
article |
119 |
Healthcare providers’ perceptions of the surgical treatment for male breast cancer: Time to add surgical options other than mastectomy to the discussion
|
Levin Dagan, N. |
|
|
175 |
S1 |
p. S22 |
article |
120 |
HER2-low versus HER2-0 in Invasive Lobular Breast Carcinoma
|
Fontes-Sousa, M. |
|
|
175 |
S1 |
p. S86-S87 |
article |
121 |
Home based care for terminal cancer patients: study from rural part of India
|
Jana, S. |
|
|
175 |
S1 |
p. S74 |
article |
122 |
Home-monitoring of cancer-related fatigue in breast cancer patients
|
Wijlens, K.A.E. |
|
|
175 |
S1 |
p. S50-S51 |
article |
123 |
How ‘breast aware’ are the Indian women? A study among the women visiting a tertiary-care, referral and teaching hospital
|
Newton, M.V. |
|
|
175 |
S1 |
p. S44 |
article |
124 |
Imaging features of malignant lesions in women with PTEN Hamartoma Tumor Syndrome
|
Hoxhaj, A. |
|
|
175 |
S1 |
p. S88-S89 |
article |
125 |
Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis
|
Ploumen, R. |
|
|
175 |
S1 |
p. S58-S59 |
article |
126 |
Impact of axillary disease extent on baseline 18F-FDG PET/CT in clinically node-positive breast cancer patients on the accuracy of axillary surgical staging after NCT
|
De Mooij, C.M. |
|
|
175 |
S1 |
p. S15 |
article |
127 |
Impact of biomarkers and other diseases on breast cancer risk and mortality: prospective cohort study in the UK Biobank
|
Zhang, Y. |
|
|
175 |
S1 |
p. S95 |
article |
128 |
Impact of breast cancer diagnosis on women’s sexuality
|
Bannour, R. |
|
|
175 |
S1 |
p. S54 |
article |
129 |
Impact of breast cancer treatment on women’s body image and self esteem
|
Bannour, R. |
|
|
175 |
S1 |
p. S54 |
article |
130 |
Impact of lymphedema on health-related quality of life in early-stage breast cancer patients treated breast conserving therapy with or without sentinel lymph node biopsy: 2-year results from the randomized controlled trial BOOG2013–08
|
Wintraecken, V. |
|
|
175 |
S1 |
p. S51 |
article |
131 |
Impact of musical training in breast cancer patients with post-treatment cognitive, funtional and emotional sequelae
|
Anchuelo, J. |
|
|
175 |
S1 |
p. S56 |
article |
132 |
Impact of pre-existing cardiometabolic diseases on cancer stage at diagnosis in the EPIC study
|
Jansana, A. |
|
|
175 |
S1 |
p. S9-S10 |
article |
133 |
Impact of subcutaneous versus intravenous administration of pertuzumab and trastuzumab (PH) for the treatment of HER2-positive breast cancer in Montenegro
|
Cicmil Saric, N. |
|
|
175 |
S1 |
p. S72 |
article |
134 |
Information needs of individuals from BRCA-harboring families: A systematic review and content analysis
|
Park, S.Y. |
|
|
175 |
S1 |
p. S37 |
article |
135 |
Initial experience with targeted axillary dissection (TAD) guided by ultrasound in early-stage node positive breast cancer patients undergoing upfront surgery
|
Siso, C. |
|
|
175 |
S1 |
p. S25 |
article |
136 |
Interhospital variations in diagnostic work-up following recall at biennial screening mammography – a population-based study
|
Rozemond, F. |
|
|
175 |
S1 |
p. S33 |
article |
137 |
Interobserver variation in the assessment of HER2 low expression in breast cancer: can we improve by adjusting criteria? An international interobserver study
|
Baez Navarro, X. |
|
|
175 |
S1 |
p. S88 |
article |
138 |
Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal carcinoma in situ of the breast
|
Esgueva, A. |
|
|
175 |
S1 |
p. S4-S5 |
article |
139 |
Intrinsic tumor subtype in hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) treated with cyclin-dependent kinase 4/6 inhibitors (CDK 4/6i) and endocrine therapy (ET) – a retrospective analysis of real world data
|
Martins, T. |
|
|
175 |
S1 |
p. S68-S69 |
article |
140 |
Investigating The Role of Several Inner Nuclear Membrane Proteins In Triple Negative Breast Cancer
|
Rose, M. |
|
|
175 |
S1 |
p. S78 |
article |
141 |
Is sentinel lymph node biopsy without frozen section in early stage breast cancer sufficient in accordance with ACOSOG-Z0011? A retrospective review from King Chulalongkorn Memorial Hospital
|
Treeratanapun, N. |
|
|
175 |
S1 |
p. S21 |
article |
142 |
Late cardiac effects in patients with left breast cancer treated with hypofractionated radiotherapy
|
Yadav, B. |
|
|
175 |
S1 |
p. S48 |
article |
143 |
Levels of vitamin D and expression of the vitamin D receptor in relation to breast cancer risk and survival
|
Huss, L. |
|
|
175 |
S1 |
p. S83-S84 |
article |
144 |
Living with the unknown: The experience of Cypriot individuals living with BRCA 1/2 mutations
|
Christodoulidou, S. |
|
|
175 |
S1 |
p. S75 |
article |
145 |
Lobular carcinoma of the breast and response to targeted therapy with CDK4/6 inhibitors – a single Portuguese center experience
|
Freitas, P. |
|
|
175 |
S1 |
p. S73 |
article |
146 |
Local recurrence of breast cancer after mastectomy. Impact of residual tissue in cancer follow-up
|
Jimenez Gomez, M. |
|
|
175 |
S1 |
p. S94-S95 |
article |
147 |
Locoregional lymph node metastasis from occult breast cancer: Treatment options and prognosis in Denmark
|
Nærum, A.W. |
|
|
175 |
S1 |
p. S16 |
article |
148 |
Long-term breast cancer risk after benign breast disease in population-based screening
|
Roman, M. |
|
|
175 |
S1 |
p. S6 |
article |
149 |
Long-term yogic intervention improves the level of TNF-α, IFN-γ, MDA, and NO in breast cancer patients undergoing chemotherapy and/or radiotherapy: A randomized control study
|
Jain, M. |
|
|
175 |
S1 |
p. S35-S36 |
article |
150 |
Magnetic delayed sentinel lymph node dissection in primary systemic therapy. Implications for enhanced axillary mapping (Update)
|
Pantiora, E. |
|
|
175 |
S1 |
p. S28 |
article |
151 |
Mammographic breast density correlated with worse prognosis of early breast cancer regardless of menopausal status
|
Lee, J.S. |
|
|
175 |
S1 |
p. S93-S94 |
article |
152 |
Margin status and Survival outcomes following breast conservation surgery: a metaanalysis
|
Bundred, N. |
|
|
175 |
S1 |
p. S24 |
article |
153 |
Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2
|
Jhaveri, K. |
|
|
175 |
S1 |
p. S2-S3 |
article |
154 |
MaThAI: A MultiModal imaging combining Mammography and Thermalytix for better prioritization of mammography scans to detect early malignancies
|
Kakileti, S.T. |
|
|
175 |
S1 |
p. S34 |
article |
155 |
Mesh-Pocket Supported Prepectoral Direct-to-Implant Breast Reconstruction: Preliminary Results of a Prospective Analysis
|
Paepke, S. |
|
|
175 |
S1 |
p. S13 |
article |
156 |
MINIVAB trial: Minimally invasive breast cancer excision using vacuum assisted biopsy under ultrasound guidance
|
Sanderink, W. |
|
|
175 |
S1 |
p. S15 |
article |
157 |
Morphometric analysis of ductal carcinoma in situ identifies features associated with low risk of progression to invasive breast cancer
|
Leite, M. |
|
|
175 |
S1 |
p. S90 |
article |
158 |
Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 100 high risk families with breast cancer: A single center study
|
Lee, J.S. |
|
|
175 |
S1 |
p. S37 |
article |
159 |
Neoadjuvant treatment for breast cancer patients in a Venezuelan breast center. Pathologic complete response: is it worth it?
|
Acosta-Marin, V. |
|
|
175 |
S1 |
p. S62-S63 |
article |
160 |
Neratinib could be effective as monotherapy or in combination with Trastuzumab in HER2 low expressing breast cancer cells and organoid model
|
Arshad, M. |
|
|
175 |
S1 |
p. S77 |
article |
161 |
Nipple-sparing mastectomy with primary breast reconstruction: Breast cancer local recurrence according to molecular subtype
|
Golijanin, D. |
|
|
175 |
S1 |
p. S26-S27 |
article |
162 |
Non-Inflammatory skin involvement in Breast Cancer (T4b): Real-world Data from a Tertiary care centre in Eastern India
|
Deepika, S. |
|
|
175 |
S1 |
p. S72-S73 |
article |
163 |
North East England outcomes in node positive breast cancer from the real world use of 21 gene recurrence score testing
|
Gault, A. |
|
|
175 |
S1 |
p. S66-S67 |
article |
164 |
Novel breast cancer predisposing candidate genes identified in Brazilian families with hereditary breast cancer
|
Bandeira, G. |
|
|
175 |
S1 |
p. S39 |
article |
165 |
Oesophagus exposure in hypofractionated breast cancer radiotherapy: an organ at risk commonly overlooked?
|
Naimi, Z. |
|
|
175 |
S1 |
p. S47 |
article |
166 |
Oncologic outcome of Immediate Breast Reconstruction after mastectomy in breast cancer patients: A Systematic reviews and Meta-Analysis
|
Kim, H.Y. |
|
|
175 |
S1 |
p. S13 |
article |
167 |
Oncophone20 study: Patients’ perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers
|
Picardo, E. |
|
|
175 |
S1 |
p. S10 |
article |
168 |
One-step nucleic acid amplification assay in palpable and non-palpable breast tumours
|
Robalo Cordeiro, M. |
|
|
175 |
S1 |
p. S81 |
article |
169 |
Our early experience with Magseed and Savi-scout localization against wire localization Breast conserving surgery in impalpable breast cancer
|
Tin, S.M.M. |
|
|
175 |
S1 |
p. S69 |
article |
170 |
Ovarian function suppression in early & locally advanced breast cancer: an audit of practice
|
Roberts, N. |
|
|
175 |
S1 |
p. S61-S62 |
article |
171 |
Overview of patient preference sensitive attributes in eHealth interventions for breast cancer-related fatigue
|
Beenhakker, L. |
|
|
175 |
S1 |
p. S52 |
article |
172 |
PAM50 genomic test in the management of early breast cancer – the importance of clinical-pathological data
|
Valente, A. |
|
|
175 |
S1 |
p. S77 |
article |
173 |
Papillary carcinoma of breast – Clinicopathological characteristics, management, and survival
|
Rehman, B. |
|
|
175 |
S1 |
p. S23 |
article |
174 |
Pathogenic mutations in ethnic Lebanese Arab patients with high risk for hereditary breast cancer
|
Moukadem, H. |
|
|
175 |
S1 |
p. S38 |
article |
175 |
Pathologic complete response in triple negative breast cancer - A single Portuguese center experience
|
Pina, A. |
|
|
175 |
S1 |
p. S66 |
article |
176 |
PATHways UK survey: Pathology perceptions on current biomarker testing and pathways for breast cancer in England
|
Taniere, P. |
|
|
175 |
S1 |
p. S90-S91 |
article |
177 |
Patient-assisted versus standard compression in mammography screening: A randomized trial
|
Louro, J. |
|
|
175 |
S1 |
p. S32 |
article |
178 |
Patterns and predictors of cancer-related fatigue domains after breast cancer: the influence of lifestyle
|
Witteveen, A. |
|
|
175 |
S1 |
p. S45 |
article |
179 |
Peer Review Policy for the European Journal of Cancer (EJC)
|
|
|
|
175 |
S1 |
p. iii |
article |
180 |
Perceived injustice in cancer survivors: an exploration and a population-specific cut-off score
|
Roose, E. |
|
|
175 |
S1 |
p. S51-S52 |
article |
181 |
Peripheral blood neutrophil/lymphocyte ratio as a prognostic factor in triple negative breast cancer
|
Mendes, A.S. |
|
|
175 |
S1 |
p. S32 |
article |
182 |
Plasma L-arginine metabolic profiling in breast cancer patients reflects differences in cellular gene expression and metabolic activities according to subtype – A translational study in human breast cancer
|
Hannemann, J. |
|
|
175 |
S1 |
p. S83 |
article |
183 |
Postoperative breast radiotherapy using deformable image registration of initial PET-CT before NAC
|
Shiraishi, K. |
|
|
175 |
S1 |
p. S49 |
article |
184 |
Post-treatment quality of life among Sri Lankan women with breast cancer
|
Seneviratne, S. |
|
|
175 |
S1 |
p. S55 |
article |
185 |
Predicting factors of local recurrence in ductal carcinoma in situ of the breast
|
Pumarola Brussosa, C. |
|
|
175 |
S1 |
p. S96 |
article |
186 |
Prediction of axillary complete pathological response after neoadyuvant treatment in breast cancer cN1 patients
|
Jimeno Fraile, J. |
|
|
175 |
S1 |
p. S64-S65 |
article |
187 |
Prediction of histological grade and molecular subtypes of invasive breast cancer using mammographic growth rate in screening
|
Peters, J. |
|
|
175 |
S1 |
p. S34 |
article |
188 |
Predictive factors of macrometastasis in sentinel lymph node in invasive lobular carcinoma
|
Julià, C. |
|
|
175 |
S1 |
p. S18-S19 |
article |
189 |
Preoperative MRI in women with newly diagnosed breast cancer: re-excision rates and additional findings
|
Eriksson, J. |
|
|
175 |
S1 |
p. S31-S32 |
article |
190 |
Preoperative partial breast irradiation in low-risk breast cancer patients: a systematic review of literature
|
Civil, Y. |
|
|
175 |
S1 |
p. S46 |
article |
191 |
Primary location of breast cancer and total tumor load of the sentinel lymph node
|
David, D. |
|
|
175 |
S1 |
p. S92 |
article |
192 |
Primary results of ANZ 1002 : Post-operative Radiotherapy Omission in Selected Patients with Early breast Cancer Trial (PROSPECT) following pre-operative breast MRI
|
Mann, B. |
|
|
175 |
S1 |
p. S47 |
article |
193 |
Prognostic impact of HER low expression in early breast cancer in a Tunisian center
|
Rachdi, H. |
|
|
175 |
S1 |
p. S82 |
article |
194 |
PRO Hair Safe Study: The patient’s perspective on the effects of scalp cooling on hair preservation
|
Brunner, C. |
|
|
175 |
S1 |
p. S61 |
article |
195 |
Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress
|
Tonk, C.H. |
|
|
175 |
S1 |
p. S71-S72 |
article |
196 |
Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes
|
Holt, F. |
|
|
175 |
S1 |
p. S46-S47 |
article |
197 |
Psychosocial factors and the incidence of breast cancer: two-stage individual participant data meta-analyses
|
Van Tuijl, L. |
|
|
175 |
S1 |
p. S6-S7 |
article |
198 |
Quality of life and lymphedema incidence after axillary surgery in pN1 breast cancer patients: lymphadenectomy vs. Sentinel lymph node biopsy
|
Jimeno Fraile, J. |
|
|
175 |
S1 |
p. S27-S28 |
article |
199 |
Quality of life and patient satisfaction after nipple sparing mastectomy versus skin sparing mastectomy and immediate one stage versus two stages breast reconstruction
|
Angelidou, E. |
|
|
175 |
S1 |
p. S22 |
article |
200 |
Quality of life in postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study
|
Arraras, J.I. |
|
|
175 |
S1 |
p. S57 |
article |
201 |
Quality of Life of breast cancer patients with COVID-19 disease
|
Arraras, J.I. |
|
|
175 |
S1 |
p. S62 |
article |
202 |
Racial disparity and time to treatment initiation effects on survival differences in breast cancer: a DAGs-based review protocol for a systematic review of cohort studies
|
Mokhtari Hesari, P. |
|
|
175 |
S1 |
p. S74-S75 |
article |
203 |
Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
|
Visani, L. |
|
|
175 |
S1 |
p. S48-S49 |
article |
204 |
Randomised controlled trial of breast conserving therapy: 30 year analysis of the Scottish breast conservation trial
|
Williams, L. |
|
|
175 |
S1 |
p. S1-S2 |
article |
205 |
Real world evidence from a Breast Screening pilot for the underprivileged: Experiences from Bruhat Bengaluru Mahanagara Palike hospitals
|
Manjunath, G. |
|
|
175 |
S1 |
p. S30 |
article |
206 |
Real-world use of multigene signatures in early breast cancer: the experience by the Lombardy Genomic Assays for Breast Cancer Working Group
|
Licata, L. |
|
|
175 |
S1 |
p. S91 |
article |
207 |
Residual Risk of Relapse: a Systematic Review and a Consensus Project on Unmet needs for HER2-positive non Metastatic Breast Cancer Patients
|
Miglietta, F. |
|
|
175 |
S1 |
p. S57-S58 |
article |
208 |
Results from a large single institute experience of targeted intraoperative radiotherapy (TARGIT-IORT) as partial breast irradiation modality
|
Vinante, L. |
|
|
175 |
S1 |
p. S49 |
article |
209 |
Retrospective thorough analysis of regional lymph node recurrence in breast cancer patients (REASON Trial)
|
Liapi, A. |
|
|
175 |
S1 |
p. S63 |
article |
210 |
Risk factors of complications after nipple-sparing mastectomies in women with breast cancer risk gene mutations (BRCA1, BRCA2, PALB2)
|
De La Torre-Fernandez De Vega, J. |
|
|
175 |
S1 |
p. S43 |
article |
211 |
Role of perioperative tranexamic acid in reducing drain volume in breast cancer patients undergoing axillary lymph node dissection: A randomized controlled trial
|
Deepika, S. |
|
|
175 |
S1 |
p. S19 |
article |
212 |
Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis: a population-based study
|
Eijkelboom, A. |
|
|
175 |
S1 |
p. S10 |
article |
213 |
SAFE: A Microwave Imaging Device for Breast Cancer Early Screening
|
Akduman, I. |
|
|
175 |
S1 |
p. S32-S33 |
article |
214 |
Screen-detected breast cancers have an improved 5-year recurrence free interval compared to interval and non-screened breast cancers: a population-based study
|
de Munck, L. |
|
|
175 |
S1 |
p. S31 |
article |
215 |
Second primary cancer risks for female and male breast cancer survivors in England
|
Allen, I. |
|
|
175 |
S1 |
p. S11-S12 |
article |
216 |
Selective pectoralis major muscle denervation in retro-pectoral implant based breast reconstruction reduces capsular contracture rate. Long-term single institution prospective case-control study
|
Bernini, M. |
|
|
175 |
S1 |
p. S23 |
article |
217 |
Sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial
|
Masó, P. |
|
|
175 |
S1 |
p. S16 |
article |
218 |
Serum methylmalonic acid concentrations at breast cancer diagnosis are not associated with distant metastases
|
Wu, Q. |
|
|
175 |
S1 |
p. S76-S77 |
article |
219 |
Shared decision-making in breast cancer care: Evidence from a scoping literature review and a survey across breast units in Europe
|
Oprea, N. |
|
|
175 |
S1 |
p. S73-S74 |
article |
220 |
Short-term surgical complications of skin-sparing mastectomy and direct-to-implant immediate breast reconstruction in women concurrently treated with adjuvant radiotherapy for breast cancer (2022; archives of plastic surgery (aps))
|
Kooijman, M. |
|
|
175 |
S1 |
p. S20-S21 |
article |
221 |
Single nucleotide polymorphisms of ABCB1 (rs1128503) and ABCC2 (rs145008610) genes and its clinical impact in ER & PR positive breast cancer patients in a tertiary care hospital of India
|
Mistry, T. |
|
|
175 |
S1 |
p. S79 |
article |
222 |
Sonographic assessment of the axilla in breast cancer: changing the threshold
|
James, S. |
|
|
175 |
S1 |
p. S89 |
article |
223 |
Spatial Immunophenotyping Identifies Differential Infiltration of Immunosuppressive Subsets in Tumor Stroma and Invasive Margin and PDL1 expression in Inflammatory and non-Inflammatory Breast Cancer Patients overexpressing X-Linked Inhibitor of Apoptosis Protein
|
Van Berckelaer, C. |
|
|
175 |
S1 |
p. S87 |
article |
224 |
SPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapy
|
Dilege, E. |
|
|
175 |
S1 |
p. S17 |
article |
225 |
Superior survival after breast conserving therapy versus mastectomy – a multicenter Asian cohort study of 3655 patients
|
Leong, F. |
|
|
175 |
S1 |
p. S18 |
article |
226 |
Surgical choices and complications in elderly women: a single center retrospective analysis in frail vs non frail breast cancer patients
|
Costa, P. |
|
|
175 |
S1 |
p. S84 |
article |
227 |
Surgical outcomes after neoadjuvant systemic therapy in patients with lobular carcinoma
|
Van Hemert, A. |
|
|
175 |
S1 |
p. S17 |
article |
228 |
Systemic therapies post progression on CDK4/6 inhibitors in patients with oestrogen receptor positive metastatic breast cancer: Real world data from Guy’s Cancer Centre
|
Gousis, C. |
|
|
175 |
S1 |
p. S65 |
article |
229 |
Targeted axillary dissection or sentinel node biopsy after neo-adjuvant treatment in clinically node positive patients – the West of Scotland experience
|
Romics, L. |
|
|
175 |
S1 |
p. S17-S18 |
article |
230 |
The combination of platelet-to-lymphocyte ratios with TIL assessment as prognostic factor for patients with triple negative breast cancer
|
Horimoto, Y. |
|
|
175 |
S1 |
p. S86 |
article |
231 |
The development of an interactive online referral tool for breast services in Wales: optimising the patient referral pathway
|
Gohobur, S. |
|
|
175 |
S1 |
p. S90 |
article |
232 |
The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review
|
van Maaren, M. |
|
|
175 |
S1 |
p. S11 |
article |
233 |
The effect of behavioral graded activity on physical activity level, health-related quality of life, and symptom management in cancer patients and survivors: systematic review and meta-analysis
|
Lahousse, A. |
|
|
175 |
S1 |
p. S9 |
article |
234 |
The effect of intra-operative margin assessment during breast conserving surgery for breast cancer in a Dutch cohort
|
Wooldrik, S. |
|
|
175 |
S1 |
p. S25 |
article |
235 |
The effect of prehabilitation in cancer patients: systematic review and meta-analysis
|
Lahousse, A. |
|
|
175 |
S1 |
p. S40 |
article |
236 |
The impact of therapeutic drug monitoring-based tamoxifen dose-reductions on endocrine side effects in patients with primary breast cancer
|
Buijs, S. |
|
|
175 |
S1 |
p. S58 |
article |
237 |
The Impact on Management and Outcomes of Benign and High-Risk Breast Lesions After the Introduction of Vacuum Assisted Excision
|
Wooldrik, S. |
|
|
175 |
S1 |
p. S26 |
article |
238 |
The mediating effect of pain catastrophizing and perceived injustice in the relationship of pain on health-related quality of life in breast cancer survivors
|
Roose, E. |
|
|
175 |
S1 |
p. S54 |
article |
239 |
The mediating effect of perceived injustice and pain catastrophizing in the relationship of pain on fatigue and sleep in breast cancer survivors: a cross-sectional study
|
Lahousse, A. |
|
|
175 |
S1 |
p. S50 |
article |
240 |
The place of videos illustrating the techniques of breast surgery in the procedural training of residents in gynecology
|
Bannour, B. |
|
|
175 |
S1 |
p. S25 |
article |
241 |
The positive predictive value of breast lesions of uncertain malignant potential, their correlation with radiologic findings and their follow-up on a large single-institution series
|
Bernini, M. |
|
|
175 |
S1 |
p. S24-S25 |
article |
242 |
The psycho-emotional condition of the spouses of breast cancer patients
|
Georgiou, A. |
|
|
175 |
S1 |
p. S36-S37 |
article |
243 |
The relationship among bowel FDG-PET uptake, pathological complete response, and eating habits in breast cancer patients undergoing neoadjuvant chemotherapy
|
Tiberio, P. |
|
|
175 |
S1 |
p. S63-S64 |
article |
244 |
The role of axillary staging in patients with Ductal Carcinoma In Situ (DCIS) on diagnostic tissue biopsy
|
Jain, U. |
|
|
175 |
S1 |
p. S28-S29 |
article |
245 |
The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe
|
Schmitz, R. |
|
|
175 |
S1 |
p. S3-S4 |
article |
246 |
The utility of virtual clinics in the assessment of patients with mastalgia: a model for breast services post-pandemic?
|
Regan, A. |
|
|
175 |
S1 |
p. S89 |
article |
247 |
The value of palpation, US and NMR in staging of axilla in patients with breast cancer in order to avoid unnecessary ALND
|
Maksimovic, Z. |
|
|
175 |
S1 |
p. S23-S24 |
article |
248 |
Time to surgery after completion of neoadjuvant chemotherapy does not negatively impact recurrence and survival outcomes in breast cancer patients
|
Bek, S. |
|
|
175 |
S1 |
p. S27 |
article |
249 |
Title Page
|
|
|
|
175 |
S1 |
p. i |
article |
250 |
Trained Artificial Intelligence (AI) for Predicting Therapy Discontinuation Based on Patient Observations in Advanced Breast Cancer
|
Kates, R.E. |
|
|
175 |
S1 |
p. S72 |
article |
251 |
Triple negative breast cancers: Rising menace in the developing world and treatment challenges
|
Patel, S. |
|
|
175 |
S1 |
p. S93 |
article |
252 |
Tumor-Infiltrating lymphocytes and its relationship with survival in a series of primary breast cancer patients according to the different surrogated molecular subtypes
|
Falo Zamora, C. |
|
|
175 |
S1 |
p. S96 |
article |
253 |
Tumour characteristics and radiological response are better predictors than tumour extent of axillary pathological complete response after neoadjuvant systemic therapy
|
Du De Xuan, S. |
|
|
175 |
S1 |
p. S18 |
article |
254 |
Ultrahypofractionated radiation therapy for breast cancer: two-year normal tissue effects
|
Oulkadi, R. |
|
|
175 |
S1 |
p. S46 |
article |
255 |
Ultrasound measurement of the distance between the breast tumor and the skin: a cut-off value for safe skin preservation. Diagnostic accuracy study
|
Brandão, R. |
|
|
175 |
S1 |
p. S22 |
article |
256 |
Underestimated risk of involved margins in Skin (SMM)- and Nipple Sparing Mastectomies (NSM) – Data and Multimodal Approach for Improvement
|
Paepke, S. |
|
|
175 |
S1 |
p. S13-S14 |
article |
257 |
Unusual ocular manifestations of breast carcinoma: A single institute case series in the Indian population
|
Murali-Nanavati, S. |
|
|
175 |
S1 |
p. S69 |
article |
258 |
Update of the European Breast Cancer Guidelines for Screening and Diagnosis: priority questions and new topics
|
Morgano, G.P. |
|
|
175 |
S1 |
p. S31 |
article |
259 |
Usability test of BREAST-Q questionnaires during pre-implementation of Patient-Reported Outcomes Measures in a Plastic- and Breast Surgical Outpatient Clinic
|
Prüsse, J. |
|
|
175 |
S1 |
p. S80-S81 |
article |
260 |
Use of Arista™ AH Absorbable Hemostat in breast surgery – analysis of seroma volumes and duration of drainage
|
Klein, E. |
|
|
175 |
S1 |
p. S14 |
article |
261 |
Use of frailty measurements in observational studies on older patients with breast cancer: A systematic review
|
Sanchez, D. |
|
|
175 |
S1 |
p. S94 |
article |
262 |
Use of immersive virtual reality for management of anxiety and depression among chemotherapy-naïve Filipino breast cancer outpatients in a national university hospital
|
Ando, M. |
|
|
175 |
S1 |
p. S35 |
article |
263 |
Utility Of Telephone-Based Psychological Support Among Breast Cancer Patients During Covid-19 Pandemic: An Observational Study
|
Datta, A. |
|
|
175 |
S1 |
p. S74 |
article |
264 |
Validation Sentinel Lymph Node Biopsy Study in post NACT cN0 Axilla using low-cost dual dye technique: Potential Solution for Resource Poor Settings
|
Chavda, J. |
|
|
175 |
S1 |
p. S20 |
article |
265 |
What are women’s perceptions of diagnostic DBT and targeted breast ultrasound for the evaluation of their focal breast complaints?
|
Siebers, C. |
|
|
175 |
S1 |
p. S92-S93 |
article |
266 |
Who is at risk of developing breast cancer-related fatigue – a prediction study
|
Beenhakker, L. |
|
|
175 |
S1 |
p. S52-S53 |
article |